港股異動丨電子煙概念股再度集體走強 市場憧憬電子煙可在穩定監管環境經營
格隆匯11月15日丨電子煙概念股再度集體走強,中國波頓大漲近11%,思摩爾國際漲近5%。上週五,有電子煙企業曬出邀請函,稱受國家煙草專賣局《電子煙》國標項目組邀請,參加了其召開的國標徵求意見會,會議討論內容包括122種電子煙添加劑白名單以及每毫升尼古丁含量等細則。一時間,電子煙“國標”即將落地的消息甚囂塵上,儘管消息尚未得到官方途徑認可,但電子煙“概念股”已經連續兩日走強,市場憧憬電子煙可在穩定監管環境經營。

Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.